- Investing Ideas
- Global Pharmaceuticals & Biotech Large Cap High Growth Potential
Global Pharmaceuticals & Biotech Large Cap High Growth Potential
Results
56
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
56 companies
Axsome Therapeutics
Market Cap: US$11.3b
A biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.
AXSM
US$204.07
7D
-1.8%
1Y
78.9%
Madrigal Pharmaceuticals
Market Cap: US$12.5b
A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.
MDGL
US$523.26
7D
-2.0%
1Y
22.5%
Sichuan Kelun-Biotech Biopharmaceutical
Market Cap: HK$110.5b
A biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, metabolism, and other therapeutic areas in the People’s Republic of China and internationally.
6990
HK$460.60
7D
-4.2%
1Y
-10.0%
Insmed
Market Cap: US$27.4b
Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.
INSM
US$119.92
7D
-4.0%
1Y
-17.2%
ALTEOGEN
Market Cap: ₩18.1t
A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.
A196170
₩255,500.00
7D
-8.6%
1Y
-29.8%
PharmaEssentia
Market Cap: NT$499.4b
A biopharmaceutical company engages in medicine discovery, supplements in developing specialty pharmaceutical reagents, API, and new drug patterns developments in the Americas, Europe, Asia, and Taiwan.
6446
NT$1,205.00
7D
-10.4%
1Y
176.5%
Akeso
Market Cap: HK$87.7b
A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of antibody drugs worldwide.
9926
HK$90.40
7D
-4.9%
1Y
-29.9%
WuXi XDC Cayman
Market Cap: HK$95.2b
An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.
2268
HK$74.85
7D
0.6%
1Y
6.1%
Alnylam Pharmaceuticals
Market Cap: US$33.5b
Alnylam Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes therapeutics based on ribonucleic acid interference in the United States, Europe, and internationally.
ALNY
US$238.27
7D
-8.4%
1Y
-48.3%
Revolution Medicines
Market Cap: US$44.0b
A clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers.
RVMD
US$204.86
7D
-1.2%
1Y
358.3%
Corcept Therapeutics
Market Cap: US$12.1b
A biopharmaceutical company, engages in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.
CORT
US$110.82
7D
-2.8%
1Y
55.4%
argenx
Market Cap: €53.7b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€858.80
7D
-0.8%
1Y
36.2%
BridgeBio Pharma
Market Cap: US$14.1b
A biopharmaceutical company, discovers, develops, and delivers medicines for patients with genetic diseases.
BBIO
US$68.39
7D
-8.5%
1Y
32.8%
Krystal Biotech
Market Cap: US$10.1b
A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.
KRYS
US$336.68
7D
-4.2%
1Y
118.1%
Laurus Labs
Market Cap: ₹1.0t
Manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally.
LAURUSLABS
₹1,926.90
7D
-1.0%
1Y
115.3%
Torrent Pharmaceuticals
Market Cap: ₹1.8t
Engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, Malta, and internationally.
500420
₹4,850.00
7D
-2.3%
1Y
37.3%
Sandoz Group
Market Cap: CHF 28.5b
Develops, manufactures, and markets generic and biosimilars worldwide.
SDZ
CHF 65.78
7D
-3.5%
1Y
40.1%
Viatris
Market Cap: US$19.1b
Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.
VTRS
US$16.65
7D
0.2%
1Y
74.2%
Tempus AI
Market Cap: US$11.2b
Operates as a healthcare technology company in the United States.
TEM
US$68.85
7D
7.1%
1Y
-20.9%
AstraZeneca
Market Cap: UK£187.9b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
UK£121.16
7D
2.0%
1Y
6.8%
Sartorius Stedim Biotech
Market Cap: €18.5b
Engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide.
DIM
€190.00
7D
-0.2%
1Y
8.4%
Galderma Group
Market Cap: CHF 35.7b
Operates as a dermatology company worldwide.
GALD
CHF 153.30
7D
-5.8%
1Y
6.1%
Ascendis Pharma
Market Cap: US$17.4b
Operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally.
ASND
US$239.77
7D
-11.2%
1Y
n/a
Merck
Market Cap: US$357.4b
Operates as a healthcare company worldwide.
MRK
US$143.79
7D
-3.1%
1Y
77.3%
AbbVie
Market Cap: US$462.6b
A research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.
ABBV
US$263.04
7D
5.7%
1Y
21.6%
Chugai Pharmaceutical
Market Cap: JP¥10.7t
Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
4519
JP¥6,446.00
7D
-0.5%
1Y
-4.1%
Innovent Biologics
Market Cap: HK$165.4b
A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, Europe, and internationally.
1801
HK$94.10
7D
-4.2%
1Y
-2.5%
BeOne Medicines
Market Cap: US$40.2b
An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.
ONC
US$346.50
7D
-1.4%
1Y
5.9%
Swedish Orphan Biovitrum
Market Cap: SEK 153.0b
A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.
SOBI
SEK 439.60
7D
-3.8%
1Y
57.4%
Gilead Sciences
Market Cap: US$181.5b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILD
US$146.30
7D
-0.2%
1Y
32.0%
Recordati Industria Chimica e Farmaceutica
Market Cap: €10.8b
Researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally.
REC
€52.65
7D
1.3%
1Y
-0.7%
Natera
Market Cap: US$49.3b
A diagnostics company, engages in the development and commercialization of molecular testing services worldwide.
NTRA
US$350.78
7D
8.2%
1Y
100.4%
Avantor
Market Cap: US$10.3b
Engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.
AVTR
US$15.44
7D
1.2%
1Y
21.5%
Novartis
Market Cap: CHF 216.4b
Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
NOVN
CHF 113.84
7D
1.8%
1Y
17.5%
Biogen
Market Cap: US$32.1b
Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally.
BIIB
US$216.17
7D
1.7%
1Y
50.5%
Takeda Pharmaceutical
Market Cap: JP¥9.3t
Engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products.
4502
JP¥5,847.00
7D
4.1%
1Y
32.0%